Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Notes Payables (2019 - 2025)

Rockwell Medical's Notes Payables history spans 7 years, with the latest figure at $264000.0 for Q4 2025.

  • For Q4 2025, Notes Payables fell 1.49% year-over-year to $264000.0; the TTM value through Dec 2025 reached $264000.0, down 1.49%, while the annual FY2025 figure was $264000.0, 1.49% down from the prior year.
  • Notes Payables reached $264000.0 in Q4 2025 per RMTI's latest filing, down from $462000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.5 million in Q2 2022 to a low of $67000.0 in Q1 2025.
  • Average Notes Payables over 5 years is $605333.3, with a median of $488000.0 recorded in 2023.
  • Peak YoY movement for Notes Payables: increased 15.1% in 2022, then crashed 51.49% in 2023.
  • A 5-year view of Notes Payables shows it stood at $437000.0 in 2021, then grew by 15.1% to $503000.0 in 2022, then plummeted by 51.49% to $244000.0 in 2023, then grew by 9.84% to $268000.0 in 2024, then fell by 1.49% to $264000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Notes Payables are $264000.0 (Q4 2025), $462000.0 (Q3 2025), and $660000.0 (Q2 2025).